This inventor holds 1 USPTO granted patent. Top assignee: Yale University. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Innovations by Toral R Patel in Nanocarrier Technology
Introduction
Toral R Patel is an accomplished inventor based in Bloomfield, CT (US). She has made significant contributions to the field of nanotechnology, particularly in the development of highly penetrative nanocarriers for the treatment of central nervous system (CNS) diseases. Her innovative work focuses on creating brain-penetrating polymeric nanoparticles that can effectively deliver drugs to targeted areas within the brain.
Latest Patents
Toral R Patel holds 1 patent for her invention titled "Highly penetrative nanocarriers for treatment of CNS disease." This patent describes brain-penetrating polymeric nanoparticles that can be loaded with drugs optimized for intracranial convection-enhanced delivery (CED). The nanoparticles are designed to target brain cancer stem cells (BCSCs) using FDA-approved compounds identified through library screening. The process involves emulsifying a polymer-drug solution, removing the solvent, and centrifuging to separate larger particles, ultimately collecting smaller particles with an average diameter of less than 100 nm, which are capable of penetrating brain interstitial spaces.
Career Highlights
Toral R Patel is affiliated with Yale University, where she continues her research and development in nanotechnology. Her work has the potential to revolutionize treatment options for patients suffering from CNS diseases, particularly brain cancer.
Collaborations
Toral has collaborated with notable colleagues, including William Mark Saltzman and Jiangbing Zhou, who have contributed to her research endeavors.
Conclusion
Toral R Patel's innovative work in nanocarrier technology represents a significant advancement in the treatment of CNS diseases. Her contributions are paving the way for more effective therapies targeting brain cancer and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
